| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Indaba Capital Management, L.P. | 9.9% | $3,302,114 | 2,751,762 | Indaba Capital Management, L.P. | 04 Feb 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX). This represents 0% of the company’s total 27,795,576 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$2,082 | 0 | |
| 2025 Q2 | 325,239 | $2,082 | $0.01 | 1 | |
| 2025 Q1 | 325,239 | $227,992 | $0.70 | 1 | |
| 2024 Q4 | 325,239 | $390,287 | $1.20 | 1 | |
| 2024 Q3 | 325,239 | $556,158 | $0 | $1.71 | 1 |
| 2024 Q2 | 325,239 | $380,529 | $0 | $1.17 | 1 |
| 2024 Q1 | 325,239 | $321,986 | -$171,464 | $0.99 | 1 |
| 2023 Q4 | 294,235 | $1,153,398 | -$24,627 | $3.92 | 2 |
| 2023 Q3 | 292,312 | $1,680,790 | -$27,247,165 | $5.75 | 2 |
| 2023 Q2 | 22,017,445 | $17,831,840 | -$1,718,876 | $0.81 | 46 |
| 2023 Q1 | 24,490,500 | $17,143,967 | -$720,822 | $0.70 | 63 |
| 2022 Q4 | 25,462,485 | $17,969,636 | -$2,260,786 | $0.71 | 69 |
| 2022 Q3 | 26,398,896 | $40,128,620 | +$12,883,590 | $1.52 | 71 |
| 2022 Q2 | 18,550,706 | $18,407,012 | -$4,675,144 | $0.99 | 61 |
| 2022 Q1 | 20,236,639 | $29,130,831 | -$1,711,961 | $1.44 | 90 |
| 2021 Q4 | 23,236,056 | $121,261,081 | +$491,919 | $5.22 | 96 |
| 2021 Q3 | 23,529,605 | $137,931,831 | -$3,022,842 | $5.83 | 103 |
| 2021 Q2 | 24,106,124 | $194,252,639 | -$4,061,932 | $8.06 | 91 |
| 2021 Q1 | 24,589,192 | $204,541,300 | -$23,799,929 | $8.32 | 96 |
| 2020 Q4 | 27,689,979 | $209,893,010 | -$8,354,009 | $7.58 | 110 |
| 2020 Q3 | 27,165,106 | $289,588,609 | -$2,803,380 | $10.66 | 109 |
| 2020 Q2 | 29,541,054 | $447,806,123 | +$4,633,079 | $15.16 | 118 |
| 2020 Q1 | 29,163,768 | $242,932,782 | -$6,110,664 | $8.33 | 100 |
| 2019 Q4 | 30,235,734 | $510,962,732 | +$12,287,490 | $16.90 | 102 |
| 2019 Q3 | 25,766,429 | $478,507,174 | +$934,063 | $18.57 | 108 |
| 2019 Q2 | 29,068,241 | $665,121,466 | +$51,009,611 | $22.88 | 111 |
| 2019 Q1 | 26,950,896 | $566,547,380 | -$5,993,465 | $21.02 | 108 |
| 2018 Q4 | 27,382,513 | $314,946,453 | +$10,081,535 | $11.50 | 101 |
| 2018 Q3 | 26,494,703 | $607,904,970 | +$45,139,765 | $22.95 | 114 |
| 2018 Q2 | 24,484,548 | $545,998,652 | +$80,316,917 | $22.30 | 112 |
| 2018 Q1 | 20,884,201 | $477,195,475 | -$142,261 | $22.85 | 113 |
| 2017 Q4 | 20,728,922 | $543,155,858 | -$30,021,361 | $26.20 | 111 |
| 2017 Q3 | 22,070,068 | $495,397,532 | +$43,046,118 | $22.45 | 113 |
| 2017 Q2 | 20,241,250 | $553,573,286 | +$12,755,160 | $27.35 | 114 |
| 2017 Q1 | 20,315,256 | $492,364,208 | +$161,522,849 | $24.20 | 94 |
| 2016 Q4 | 15,148,969 | $314,351,271 | +$14,279,372 | $20.75 | 103 |
| 2016 Q3 | 14,391,055 | $392,294,474 | +$29,290,433 | $27.26 | 98 |
| 2016 Q2 | 13,556,644 | $195,816,651 | -$4,162,247 | $14.39 | 93 |
| 2016 Q1 | 13,689,300 | $196,431,827 | -$7,701,440 | $14.37 | 89 |
| 2015 Q4 | 13,599,931 | $290,948,310 | +$71,230,645 | $21.49 | 93 |
| 2015 Q3 | 10,400,675 | $168,280,869 | +$261,666 | $16.18 | 87 |
| 2015 Q2 | 9,810,831 | $253,209,742 | +$36,170,587 | $25.81 | 83 |
| 2015 Q1 | 8,612,876 | $193,764,181 | +$18,675,960 | $22.50 | 71 |
| 2014 Q4 | 7,807,573 | $149,921,645 | +$11,782,962 | $19.19 | 75 |
| 2014 Q3 | 5,335,435 | $114,593,901 | +$11,356,856 | $21.48 | 70 |
| 2014 Q2 | 4,728,085 | $122,931,140 | -$84,661,047 | $26.00 | 71 |
| 2014 Q1 | 8,850,304 | $192,880,456 | +$112,546,198 | $21.81 | 55 |